Department of Pharmaceutical Sciences, College of Pharmacy and Health Science, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
Int J Mol Sci. 2024 May 1;25(9):4949. doi: 10.3390/ijms25094949.
Antimicrobial resistance (AMR) poses an emanating threat to humanity's future. The effectiveness of commonly used antibiotics against microbial infections is declining at an alarming rate. As a result, morbidity and mortality rates are soaring, particularly among immunocompromised populations. Exploring alternative solutions, such as medicinal plants and iodine, shows promise in combating resistant pathogens. Such antimicrobials could effectively inhibit microbial proliferation through synergistic combinations. In our study, we prepared a formulation consisting of Miller (AV), Thymol, iodine (I), and polyvinylpyrrolidone (PVP). Various analytical methods including SEM/EDS, UV-vis, Raman, FTIR, and XRD were carried out to verify the purity, composition, and morphology of AV-PVP-Thymol-I. We evaluated the inhibitory effects of this formulation against 10 selected reference strains using impregnated sterile discs, surgical sutures, gauze bandages, surgical face masks, and KN95 masks. The antimicrobial properties of AV-PVP-Thymol-I were assessed through disc diffusion methods against 10 reference strains in comparison with two common antibiotics. The 25-month-old formulation exhibited slightly lower inhibitory zones, indicating changes in the sustained-iodine-release reservoir. Our findings confirm AV-PVP-Thymol-I as a potent antifungal and antibacterial agent against the reference strains, demonstrating particularly strong inhibitory action on surgical sutures, cotton bandages, and face masks. These results enable the potential use of the formulation AV-PVP-Thymol-I as a promising antimicrobial agent against wound infections and as a spray-on contact-killing agent.
抗微生物药物耐药性(AMR)对人类的未来构成了严重威胁。常用抗生素治疗微生物感染的效果正在以惊人的速度下降。结果,发病率和死亡率正在飙升,尤其是在免疫功能低下的人群中。探索替代解决方案,如药用植物和碘,显示出在对抗耐药病原体方面的希望。这些抗菌剂可以通过协同组合有效地抑制微生物的增殖。在我们的研究中,我们制备了一种由 AV、百里酚、碘(I)和聚乙烯吡咯烷酮(PVP)组成的制剂。采用 SEM/EDS、UV-vis、拉曼、FTIR 和 XRD 等各种分析方法验证了 AV-PVP-Thymol-I 的纯度、组成和形态。我们使用浸渍无菌圆盘、手术缝线、纱布绷带、手术口罩和 KN95 口罩评估了该制剂对 10 种选定参考菌株的抑制效果。通过圆盘扩散法评估了 AV-PVP-Thymol-I 对 10 种参考菌株的抗菌性能,并与两种常用抗生素进行了比较。25 个月龄的制剂显示出稍低的抑菌圈,表明持续释放碘的储库发生了变化。我们的研究结果证实了 AV-PVP-Thymol-I 作为一种针对参考菌株的有效抗真菌和抗菌剂,对手术缝线、棉绷带和口罩表现出特别强的抑制作用。这些结果使 AV-PVP-Thymol-I 制剂有潜力用作对抗伤口感染的有前途的抗菌剂,并用作喷雾接触杀伤剂。